AMANDA JOHNSON: Open Payments
NPI 1538620356 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,046 in 165 payments from 18 companies in 2025. Trend: 2023 $3,189 · 2024 $5,139 · 2025 $2,046
Food & beverage: $2,046
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $296 |
| Lundbeck LLC | 29 | $270 |
| Otsuka America Pharmaceutical, Inc. | 19 | $270 |
| Supernus Pharmaceuticals, Inc. | 29 | $208 |
| Alkermes, Inc. | 13 | $201 |
| E.R. Squibb & Sons, L.L.C. | 11 | $162 |
| Vanda Pharmaceuticals Inc. | 6 | $162 |
| Corium, LLC | 15 | $115 |
| Biogen, Inc. | 4 | $80 |
| Noven Therapeutics, LLC | 4 | $67 |
Products named: VRAYLAR, ABILIFY MAINTENA, Qelbree, ABILIFY ASIMTUFII, COBENFY, ARISTADA, REXULTI, FANAPT.
Industry payments across KY — which companies pay providers there.
